arrow
W

Wilfried Eberhardt

west german cancer centre
H指数:70
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung Cancer

病理完全缓解预测III期非小细胞肺癌新辅助诱导化疗及放化疗后的长期生存率

2025-11-190
OAAI
Early Years, Advanced Disease: The Unmet Need in Young Adults with Non-Small Cell Lung Cancer

早年,晚期疾病:非小细胞肺癌年轻成年患者中的未满足需求

2025-09-240
OAAI
Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome

寡转移非小细胞肺癌: 局部和当代系统治疗方法对临床结果的影响

2024-09-254
OAAI
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)
2024-08-281
OAAI
Fibroblast Activation Protein-Directed - Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
2024-07-031
PRE
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
2024-04-011
OA
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315)
2024-02-080
OAAI
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with
2024-01-010
OAAI
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study

68Ga-SSO-120 PET用于小细胞肺癌患者初始分期的单中心回顾性研究

2023-07-205
OA
SUVmax Above 20 in 18F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary

在初次诊断检查时,18F-FDG PET/CT中SUVmax高于20与未知原发癌患者的良好生存率相关

2023-06-155
OA
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry
2022-09-3012
OAAI